RNCOS

Oncology: A Major Therapeutic Area for Market Participants

Press Release   •   Oct 09, 2012 12:31 IST

Cancer is one of the greatest health challenges facing the world today. 12.7 Million cancer cases were estimated to be there around the world in 2008, and the number is expected to rise to 21 Million by 2030. These figures pose serious challenges for researchers worldwide who are exploring different approaches to tackle the menace. Gene-based therapies represent a very potent mechanism in this regard.

Several advances in this direction along with various cancer gene therapies are being actively tested in various phases of clinical trials. Numerous strategies are being adapted for the same. These vary from immunological simulation based on the expression of robust cancer antigens to the expression of anti-angiogenesis proteins or pro-drug suicide genes in cancerous tumors. With most studies reporting positive results, a major breakthrough in cancer gene therapy can be expected soon.

The report entitled, “Global Gene Therapy Market Analysis”, provides an extensive research and prudent analysis of the current status and expected position of the Global Gene Therapy Market. It provides a comprehensive overview of the advanced gene therapy drugs along with recent industry developments to provide a balanced outlook on the market potential.  Moreover, the report gives an effective insight into the gene therapy clinical trials that are being progressed in different phases of research and further analyzes the use of vectors in those studies.

The report is an outcome of an in-depth research of global gene therapy market that takes into accounts all the key industry developments and participants’ activities. It also investigates the current market trends and elaborates their market impact. The report facilitates the future forecasts on overall Gene Therapy Market size by 2015. Moreover, it projects the potential market to be generated by key gene therapy products to be launched in future. It also analyzes the opportunity assessment for companies in the global gene therapy market in terms of key vectors and leading technologies.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM282.htm

Some of our Related Reports are:

- Cancer Monoclonal Antibodies Market to 2015 (http://www.rncos.com/Report/IM375.htm)
- Global Biosimilars Market Forecast to 2015 (http://www.rncos.com/Report/IM379.htm)
- US Biotech Market Analysis (http://www.rncos.com/Report/IM0300.htm)
- Global miRNA Market Outlook (http://www.rncos.com/Report/IM286.htm)
- Global HIV Therapeutics Market Analysis (http://www.rncos.com/Report/IM361.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.